ArticleJournal of neuropathology and experimental neurology2025
Comparison of multiple quantitative strategies for neuropathologic image analyses.
Article in Journal of neuropathology and experimental neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Data-driven thresholds for standardized classification of severe Alzheimer's disease neuropathology using digital neuropathology.Brain pathology (Zurich, Switzerland) · 2026Article
- Artificial intelligence-based 3D segmentation of tangle-associated TDP-43 in neurodegeneration.Brain pathology (Zurich, Switzerland) · 2026Article
- CTE has multiple pathologic variants that might relate to different clinical symptom presentation.Acta neuropathologica · 2026Article
- Proteomic Analysis of Human Chronic Traumatic Encephalopathy Brain Implicates Proteasome and Ribosome Dysfunction in Disease Progression.bioRxiv : the preprint server for biology · 2026Article
- Proteomic analysis of human chronic traumatic encephalopathy brain implicates proteasome and ribosome dysfunction in disease severity.Molecular neurodegeneration advances · 2026Article
- Genetic variation in TMEM106B alters microglial activation and cytokine responses in chronic traumatic encephalopathy.Acta neuropathologica · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The traditional semiquantitative (SQ) scoring system for neuropathologic assessment, although widely used, is prone to variability among assessors and does not capture the full spectrum of pathological changes. To address these limitations, digital pathology-based strategies like positive pixel quantitation or advanced artificial intelligence (AI) techniques have been developed. However, a comprehensive comparison of these measures has never been performed. Using 1412 cases from Boston University brain banks, human-driven SQ scoring was compared with computer-driven percent area-stained measures and AI-driven cellular density quantitation of tau pathology in the dorsolateral frontal cortex. When comparing each measure directly in all cases, we observed general agreement between measures. Because the full dataset included a large range of different neuropathologies, to reduce noise we performed a subanalysis in cases with the neurodegenerative disease chronic traumatic encephalopathy (CTE) and examined correlations with clinical and neuropathologic variables. While all methods demonstrated significant ability to predict CTE neuropathology, inconsistent background, noncellular elements, and artifacts increased variability for the positive pixel method. Thus, the AI-driven method was better at identifying pathological changes associated with sparse pathology. Overall, our results demonstrate important differences among neuropathologic assessment techniques and highlight the need for careful consideration when selecting analysis methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.